Cargando…

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes

BACKGROUND: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single nucleotide polymorphisms (SNPs)) associated with risk of developing breast cancer. A score based on the combined effect of the 94 risk alleles can be calculated to measure the global risk of breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtit, Elsa, Pivot, Xavier, Henriques, Julie, Paget-Bailly, Sophie, Fumoleau, Pierre, Rios, Maria, Bonnefoi, Hervé, Bachelot, Thomas, Soulié, Patrick, Jouannaud, Christelle, Bourgeois, Hugues, Petit, Thierry, Tennevet, Isabelle, Assouline, David, Mathieu, Marie-Christine, Jacquin, Jean-Philippe, Lavau-Denes, Sandrine, Darut-Jouve, Ariane, Ferrero, Jean-Marc, Tarpin, Carole, Lévy, Christelle, Delecroix, Valérie, Trillet-Lenoir, Véronique, Cojocarasu, Oana, Meunier, Jérôme, Pierga, Jean-Yves, Kerbrat, Pierre, Faure-Mercier, Céline, Blanché, Hélène, Sahbatou, Mourad, Boland, Anne, Bacq, Delphine, Besse, Céline, Thomas, Gilles, Deleuze, Jean-François, Pauporté, Iris, Romieu, Gilles, Cox, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568360/
https://www.ncbi.nlm.nih.gov/pubmed/28830573
http://dx.doi.org/10.1186/s13058-017-0888-4
_version_ 1783258847555616768
author Curtit, Elsa
Pivot, Xavier
Henriques, Julie
Paget-Bailly, Sophie
Fumoleau, Pierre
Rios, Maria
Bonnefoi, Hervé
Bachelot, Thomas
Soulié, Patrick
Jouannaud, Christelle
Bourgeois, Hugues
Petit, Thierry
Tennevet, Isabelle
Assouline, David
Mathieu, Marie-Christine
Jacquin, Jean-Philippe
Lavau-Denes, Sandrine
Darut-Jouve, Ariane
Ferrero, Jean-Marc
Tarpin, Carole
Lévy, Christelle
Delecroix, Valérie
Trillet-Lenoir, Véronique
Cojocarasu, Oana
Meunier, Jérôme
Pierga, Jean-Yves
Kerbrat, Pierre
Faure-Mercier, Céline
Blanché, Hélène
Sahbatou, Mourad
Boland, Anne
Bacq, Delphine
Besse, Céline
Thomas, Gilles
Deleuze, Jean-François
Pauporté, Iris
Romieu, Gilles
Cox, David G.
author_facet Curtit, Elsa
Pivot, Xavier
Henriques, Julie
Paget-Bailly, Sophie
Fumoleau, Pierre
Rios, Maria
Bonnefoi, Hervé
Bachelot, Thomas
Soulié, Patrick
Jouannaud, Christelle
Bourgeois, Hugues
Petit, Thierry
Tennevet, Isabelle
Assouline, David
Mathieu, Marie-Christine
Jacquin, Jean-Philippe
Lavau-Denes, Sandrine
Darut-Jouve, Ariane
Ferrero, Jean-Marc
Tarpin, Carole
Lévy, Christelle
Delecroix, Valérie
Trillet-Lenoir, Véronique
Cojocarasu, Oana
Meunier, Jérôme
Pierga, Jean-Yves
Kerbrat, Pierre
Faure-Mercier, Céline
Blanché, Hélène
Sahbatou, Mourad
Boland, Anne
Bacq, Delphine
Besse, Céline
Thomas, Gilles
Deleuze, Jean-François
Pauporté, Iris
Romieu, Gilles
Cox, David G.
author_sort Curtit, Elsa
collection PubMed
description BACKGROUND: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single nucleotide polymorphisms (SNPs)) associated with risk of developing breast cancer. A score based on the combined effect of the 94 risk alleles can be calculated to measure the global risk of breast cancer. We aimed to test the hypothesis that the 94-SNP-based risk score is associated with clinico-pathological characteristics, breast cancer subtypes and outcomes in early breast cancer. METHODS: A 94-SNP risk score was calculated in 8703 patients in the PHARE and SIGNAL prospective case cohorts. This score is the total number of inherited risk alleles based on 94 selected SNPs. Clinical data and outcomes were prospectively registered. Genotyping was obtained from a GWAS. RESULTS: The median 94-SNP risk score in 8703 patients with early breast cancer was 77.5 (range: 58.1–97.6). The risk score was not associated with usual prognostic and predictive factors (age; tumor, node, metastasis (TNM) status; Scarff-Bloom-Richardson grade; inflammatory features; estrogen receptor status; progesterone receptor status; human epidermal growth factor receptor 2 (HER2) status) and did not correlate with breast cancer subtypes. The 94-SNP risk score did not predict outcomes represented by overall survival or disease-free survival. CONCLUSIONS: In a prospective case cohort of 8703 patients, a risk score based on 94 SNPs was not associated with breast cancer characteristics, cancer subtypes, or patients’ outcomes. If we hypothesize that prognosis and subtypes of breast cancer are determined by constitutional genetic factors, our results suggest that a score based on breast cancer risk-associated SNPs is not associated with prognosis. TRIAL REGISTRATION: PHARE cohort: NCT00381901, Sept. 26, 2006 – SIGNAL cohort: INCa RECF1098, Jan. 28, 2009 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0888-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5568360
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55683602017-08-29 Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes Curtit, Elsa Pivot, Xavier Henriques, Julie Paget-Bailly, Sophie Fumoleau, Pierre Rios, Maria Bonnefoi, Hervé Bachelot, Thomas Soulié, Patrick Jouannaud, Christelle Bourgeois, Hugues Petit, Thierry Tennevet, Isabelle Assouline, David Mathieu, Marie-Christine Jacquin, Jean-Philippe Lavau-Denes, Sandrine Darut-Jouve, Ariane Ferrero, Jean-Marc Tarpin, Carole Lévy, Christelle Delecroix, Valérie Trillet-Lenoir, Véronique Cojocarasu, Oana Meunier, Jérôme Pierga, Jean-Yves Kerbrat, Pierre Faure-Mercier, Céline Blanché, Hélène Sahbatou, Mourad Boland, Anne Bacq, Delphine Besse, Céline Thomas, Gilles Deleuze, Jean-François Pauporté, Iris Romieu, Gilles Cox, David G. Breast Cancer Res Research Article BACKGROUND: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single nucleotide polymorphisms (SNPs)) associated with risk of developing breast cancer. A score based on the combined effect of the 94 risk alleles can be calculated to measure the global risk of breast cancer. We aimed to test the hypothesis that the 94-SNP-based risk score is associated with clinico-pathological characteristics, breast cancer subtypes and outcomes in early breast cancer. METHODS: A 94-SNP risk score was calculated in 8703 patients in the PHARE and SIGNAL prospective case cohorts. This score is the total number of inherited risk alleles based on 94 selected SNPs. Clinical data and outcomes were prospectively registered. Genotyping was obtained from a GWAS. RESULTS: The median 94-SNP risk score in 8703 patients with early breast cancer was 77.5 (range: 58.1–97.6). The risk score was not associated with usual prognostic and predictive factors (age; tumor, node, metastasis (TNM) status; Scarff-Bloom-Richardson grade; inflammatory features; estrogen receptor status; progesterone receptor status; human epidermal growth factor receptor 2 (HER2) status) and did not correlate with breast cancer subtypes. The 94-SNP risk score did not predict outcomes represented by overall survival or disease-free survival. CONCLUSIONS: In a prospective case cohort of 8703 patients, a risk score based on 94 SNPs was not associated with breast cancer characteristics, cancer subtypes, or patients’ outcomes. If we hypothesize that prognosis and subtypes of breast cancer are determined by constitutional genetic factors, our results suggest that a score based on breast cancer risk-associated SNPs is not associated with prognosis. TRIAL REGISTRATION: PHARE cohort: NCT00381901, Sept. 26, 2006 – SIGNAL cohort: INCa RECF1098, Jan. 28, 2009 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0888-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-22 2017 /pmc/articles/PMC5568360/ /pubmed/28830573 http://dx.doi.org/10.1186/s13058-017-0888-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Curtit, Elsa
Pivot, Xavier
Henriques, Julie
Paget-Bailly, Sophie
Fumoleau, Pierre
Rios, Maria
Bonnefoi, Hervé
Bachelot, Thomas
Soulié, Patrick
Jouannaud, Christelle
Bourgeois, Hugues
Petit, Thierry
Tennevet, Isabelle
Assouline, David
Mathieu, Marie-Christine
Jacquin, Jean-Philippe
Lavau-Denes, Sandrine
Darut-Jouve, Ariane
Ferrero, Jean-Marc
Tarpin, Carole
Lévy, Christelle
Delecroix, Valérie
Trillet-Lenoir, Véronique
Cojocarasu, Oana
Meunier, Jérôme
Pierga, Jean-Yves
Kerbrat, Pierre
Faure-Mercier, Céline
Blanché, Hélène
Sahbatou, Mourad
Boland, Anne
Bacq, Delphine
Besse, Céline
Thomas, Gilles
Deleuze, Jean-François
Pauporté, Iris
Romieu, Gilles
Cox, David G.
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
title Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
title_full Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
title_fullStr Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
title_full_unstemmed Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
title_short Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
title_sort assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the signal/phare prospective cohort: no correlation with clinico-pathological characteristics and outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568360/
https://www.ncbi.nlm.nih.gov/pubmed/28830573
http://dx.doi.org/10.1186/s13058-017-0888-4
work_keys_str_mv AT curtitelsa assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT pivotxavier assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT henriquesjulie assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT pagetbaillysophie assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT fumoleaupierre assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT riosmaria assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT bonnefoiherve assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT bachelotthomas assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT souliepatrick assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT jouannaudchristelle assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT bourgeoishugues assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT petitthierry assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT tennevetisabelle assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT assoulinedavid assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT mathieumariechristine assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT jacquinjeanphilippe assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT lavaudenessandrine assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT darutjouveariane assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT ferrerojeanmarc assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT tarpincarole assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT levychristelle assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT delecroixvalerie assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT trilletlenoirveronique assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT cojocarasuoana assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT meunierjerome assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT piergajeanyves assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT kerbratpierre assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT fauremercierceline assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT blanchehelene assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT sahbatoumourad assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT bolandanne assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT bacqdelphine assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT besseceline assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT thomasgilles assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT deleuzejeanfrancois assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT pauporteiris assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT romieugilles assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes
AT coxdavidg assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes